newsfilter
← Latest News
ACCESS Newswire·

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results

Revenues increased 7% compared to quarter from prior year and 15% from prior quarterImprovement in gross margin for quarter of 19% compared to prior yearImprovement in net loss for quarter of $1.0 million compared to